Louis Hernandez Jr.'s Foundation For A Bright Future ("For A Bright Future, "FABF"), a non-profit organization dedicated to ...

Investment analysts at Cantor Fitzgerald increased their FY2025 earnings estimates for Gossamer Bio in a report issued on Monday, March 24th. Cantor Fitzgerald analyst O. Brayer now expects that the ...

According to a new market research report titled 'U.S. Ambulatory EHR Market Size, Share, Forecast, & Trends Analysis by Deployment Mode (Cloud/Web-based, On-premises), Type (All-in-one, Modular), ...

Investment analysts at HC Wainwright lowered their FY2028 earnings estimates for Gossamer Bio in a research note issued on ...

Sorafenib is an oral tyrosine kinase inhibitor able to inhibit VEGF receptors 1, 2 and 3, PDGF receptors α and β, RET, Flt3, c-KIT and the RAF kinase and MAPK pathways. Over 10,000 patients have ...

The most pertinent examples are PLX4032 for patients with the BRAF V600E mutation in melanoma and the use of crizotinib (a MET inhibitor that blocks ALK) for the treatment of non-small cell lung ...

Figure 2 PDGF/PDGFRA signaling pathways and agent treatments. In PDGFRA mutaled GIST. PDGF isoforms bind to the related PDGFRs, initiate distinct receptor dimerization and phosphorylation, thereby ...

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations ...

Additionally, her research identified emerging biomarkers, such as the PDGF pathway, which governs the recruitment of pericytes essential for maintaining BBB integrity. By leveraging human tissue ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.